| Followers | 843 |
| Posts | 122802 |
| Boards Moderated | 10 |
| Alias Born | 09/05/2002 |
Monday, January 18, 2010 9:13:59 PM
what makes you say that [the company is a scam]?
• CPBM claims to have an improved formulation of ribavirin: in what sense, exactly, is it improved? Ribavirin has been extensively studied by Roche and Schering-Plough (now part of Merck); if there were a simple way to improve ribavirin’s efficacy or tolerability merely by varying the formulation, these companies would have done so years ago.
• The claims in CPBM’s recent PR with respect to the timing of product launches and product-revenue streams are preposterous, IMO.
• A common technique of scam biotech companies is to hype the ownership of a licensed patent that’s inconsequential from a business standpoint. This is what CPBM appears to be doing with the 6,387,662 patent.
• Despite spending a considerable amount of time and money, no one in the drug/biotech industry has been able to develop a vaccine for HCV or has even come close to having one. IMO, the notion that a tiny virtual company will succeed in such an endeavor is patently silly.
Please see #msg-45604100 for additional comments.
Cannabix Technologies Announces First Delivery of Marijuana Breath Test (MBT) to a Major Construction Client • BLOZF • Mar 19, 2026 12:45 PM
ECGI Building in Crypto's Top-Performing Sector as Tokenized Real-World Assets Surge Past $26 Billion • ECGI • Mar 19, 2026 8:30 AM
Advances in Domestic Heavy Rare Earth Minerals Production Essential for North American Defense Stockpiles • ALOY • Mar 18, 2026 9:00 AM
ECGI Advances $10M Mortgage Tokenization Pilot as SEC Interpretation Adds Clarity • ECGI • Mar 18, 2026 8:45 AM
ECGI Advances Mortgage Tokenization Pilot as Institutional Market Rails Continue to Develop • ECGI • Mar 17, 2026 8:30 AM
Record Gold Prices Reshape Economics of New Mine Development • SNWGF • Mar 16, 2026 10:46 AM

